[
    [
        {
            "time": "2018-03-15",
            "original_text": "Dividend Stocks That Analysts Love the Most",
            "features": {
                "keywords": [
                    "Dividend",
                    "Stocks",
                    "Analysts",
                    "Love"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dividend Stocks That Analysts Love the Most",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "Novartis' Tafinlar/Mekinist Combo Gets EU Nod for 3rd Disease",
            "features": {
                "keywords": [
                    "Novartis",
                    "Tafinlar/Mekinist",
                    "EU",
                    "Nod",
                    "Disease"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Novartis' Tafinlar/Mekinist Combo Gets EU Nod for 3rd Disease",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]